Skip to Main Content

Paper Details

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer.
J Biol Chem
16
2022
-positive tumors, A10 monoclonal antibodies, EphA family isoforms, EphA10, EphA10 mAbs, EphA10-positive tumors, Ephrin receptor, T, T cell, TNBC, anti-EphA10 mAb, anti-EphA10 monoclonal antibodies, breast, lung, and ovarian cancers, chimeric, chimeric antigen receptor, chimeric antigen receptor T cells, clone #4, ephrin receptor A10, immunosuppressive myeloid cells, malignancies, mouse, patients, receptor tyrosine kinase, triple-negative breast cancer, tumor, tumors, tyrosine
Author NameAffiliation
Jun YaoThe University of Texas MD Anderson Cancer Center
Gabriel N HortobagyiThe University of Texas MD Anderson Cancer Center
Liuqing YangThe University of Texas MD Anderson Cancer Center
Mien-Chie HungGraduate Institute of Biomedical Sciences, Research Center for Cancer Biology, and Center for Molecular Medicine, China Medical University, The University of Texas MD Anderson Cancer Center, Asia University
  • 1 - 4

Datasets

Release 1.2